Long-Term Outcomes in Patients with Morbid Obesity and Type 1 Diabetes Undergoing Bariatric Surgery.

Nuria VilarrasaMiguel Angel RubioInka MiñambresLillian FloresAssumpta CaixàsAndrea CiudinMarta BuenoPedro Pablo García-LunaMaría D Ballesteros-PomarMarisol Ruiz-AdanaAlbert Lecube

Published in: Obesity surgery (2017)

Bariatric surgery in patients with T1DM mainly provides benefits of weight reduction, on insulin requirements, obesity comorbidities, and some benefits in diabetes complications, but might have only minimal effect on the glycemic control in the long term. This trial was registered at www.controlledtrials.com as ISRCTN49980913.

Keyphrases

glycemic control
weight loss
bariatric surgery
type diabetes
obese patients
blood glucose
weight gain
study protocol
clinical trial
risk factors
phase iii
cardiovascular disease
metabolic syndrome
randomized controlled trial
body mass index
adipose tissue
skeletal muscle